Skip to main content
Toggle navigation
Login
Search
Home
Biomarkers & Translational Tools (BTT)
Home
Biomarkers & Translational Tools (BTT)
Biomarkers & Translational Tools (BTT)
Type here to filter the list
LB-006 - ARTERIAL STIFFNESS AND SYSTEMIC VASCULAR CORRELATES OF BRAIN AMYLOIDOSIS AND PRECLINICAL AD
Favorite
PT-015 - EVALUATING THE UTILITY OF PROTEOMICS FOR IDENTIFICATION OF CIRCULATING PHARMACODYNAMIC BIOMARKERS FOR BIOSIMILARITY - USING PCSK-9 INHIBITOR BIOLOGICS AS A CASE STUDY
Favorite
PT-018 - MINIMAL SAMPLING TO ASSESS MECHANISMS LINKING IMMUNE CHECKPOINT INHIBITOR PHARMACOKINETICS AND OUTCOMES IN CANCER PATIENTS
Favorite
PT-019 - ESTABLISHING A PARAMOUNT QUANTITATIVE FRAMEWORK LINKING DISEASE PROGRESSION AND CLINICAL OUTCOMES FOR PARKINSONS DISEASE
Favorite
OAI-001 - CHANGES IN QTC ACROSS DIFFERENT TRIMESTERS OF PREGNANCY AND PRE-ECLAMPSIA: A SYSTEMATIC REVIEW AND META-ANALYSIS
Favorite
PII-005 - A NOVEL ENDOTYPE OF ADULT ASTHMA SUGGESTED BY PLASMA METABOLITE PROFILING OF THE COHORT FOR REALITY AND EVOLUTION OF ADULT ASTHMA IN KOREA (COREA)
Favorite
PII-006 - A SNAPSHOT OF PHARMACODYNAMIC BIOMARKERS BIOANALYSIS IN 16 BLAS APPROVED FOR NEUROLOGY INDICATIONS.
Favorite
PII-007 - CHANGES IN QTC ACROSS DIFFERENT TRIMESTERS OF PREGNANCY AND PRE-ECLAMPSIA: A SYSTEMATIC REVIEW AND META-ANALYSIS
Favorite
PII-008 - C-PEPTIDE DISEASE PROGRESSION MODEL IN INDIVIDUALS WITH NEW-ONSET TYPE 1 DIABETES
Favorite
PII-009 - DECIPHERING TYPE 1 DIABETES BY INTEGRATING ARTIFICIAL INTELLIGENCE WITH PANCREATIC WHOLE SLIDE IMAGING
Favorite
PII-010 - EVALUATION OF PLASMA BIOMARKERS TO ASSESS THEIR ABILITY TO PREDICT CYP2D6 ACTIVITY IN INDIVIDUALS INCLUDING PATIENTS WITH TYPE 2 DIABETES.
Favorite
PII-011 - FC GAMMA RECEPTORS CONTRIBUTE TO CACHEXIA MEDIATED INCREASES IN MONOCLONAL ANTIBODY CLEARANCE
Favorite
PII-012 - LEVERAGING COPROPORPHYRIN-I AS AN ENDOGENOUS OATP1B BIOMARKER TO DISENTANGLE THE EFFECTS OF CEDIROGANT IN COMPLEX DRUG-DRUG INTERACTIONS.
Favorite
PII-013 - OPTIMIZATION OF PARKINSON'S DISEASE DIGITAL BIOMARKERS THROUGH CLINICAL TRIAL SIMULATIONS.
Favorite
PII-014 - UNRAVELING IL9 SERUM DISTRIBUTION PATTERNS: INSIGHTS FROM THE CYTOCON DATABASE
Favorite
PII-015 - UTILITY OF MIROMICS AND INTEGRATIVE MULTI-OMICS SYSTEMS ANALYSIS FOR IDENTIFICATION OF MIRNAS AS POTENTIAL PHARMACODYNAMIC BIOMARKERS OF IFNβ-1A BIOLOGICS
Favorite
PWII-002 - EVALUATING THE UTILITY OF PROTEOMICS FOR IDENTIFICATION OF CIRCULATING PHARMACODYNAMIC BIOMARKERS FOR BIOSIMILARITY - USING PCSK-9 INHIBITOR BIOLOGICS AS A CASE STUDY
Favorite
PWII-003 - MINIMAL SAMPLING TO ASSESS MECHANISMS LINKING IMMUNE CHECKPOINT INHIBITOR PHARMACOKINETICS AND OUTCOMES IN CANCER PATIENTS
Favorite